Added to YB: 2021-08-31
Pitch date: 2021-08-31
BNTX:US [bullish]
BioNTech SE
-72.43%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany.
Market Cap
$17.9B
Pitch Price
$331.04
Price Target
N/A
Dividend
N/A
EV/EBITDA
-4.06
P/E
-15.84
EV/Sales
1.53
Sector
Biotechnology
Category
N/A
Show full summary:
BioNTech SE Sponsored ADR BNTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)